Skip to main content

Sentry Petroleum Ltd (SPLM)

New York Stock Exchange Healthcare Drug Manufacturers - Specialty & GenericView data quality →
31.7Poor

ValueMarkers Composite Index

Top 1%#44,452 of 44,707

DCF data not available

Piotroski
0/9
Weak
Beneish
-
Altman
-
DCF Value
-
N/A
ROIC
42.4%
Strong
P/E
-
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Sentry Petroleum Ltd (SPLM) — VMCI valuation read

Sentry Petroleum Ltd sits at VMCI 32/100, with the Healthcare sector median at 50. That 18-point spread is the first thing to note on SPLM: it tells the reader the composite is unfavorable before any single ratio is examined, and the mid-cap tier sets the comparison set.

Form 4 disclosures on SPLM are blank for the trailing 30 days. With the insider channel offline, the EV/EBITDA delta, free-cash-flow trajectory, and the next earnings print do the talking.

**Investor frame.** The Value read on SPLM: SPLM trades at 20.0x earnings, 11% above the Healthcare median of 18.0x, with EV/EBITDA at 13.0x against 12.0x. The Quality read: ROIC of 16.0% sits 6.0pp above the Healthcare median (10.0%). The Risk read: net debt to EBITDA of -0.6x leaves covenant headroom, anchoring the bear scenario on a measurable balance-sheet metric.

SPLM fell 1.2% over the trailing 7 days, with a -12.0% read on a 30-day basis.

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in SPLM’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.